Journal of medical economicsHumansBenzhydryl CompoundsSodium-Glucose Transporter 2 InhibitorsDiabetes MellitusType 2
Cardio-renal-metabolic modeling in Asia-Pacific: projections of clinical and economic burden and empagliflozin's impact on burden reduction.
Michael Kim, Emma New, Andrew Lim, Janis Lim, Jing Yi Wee, Amrita Viswambaram, Lijoy Varghese
Published: 202510.1080/13696998.2025.2590401
Abstract
AIMS: The global prevalence of cardio-renal-metabolic (CRM) conditions, including chronic kidney disease, heart failure, type 2 diabetes in interconnected pathophysiology, is rapidly increasing. This presents health/economic consequences for Asia-Pac…
Preview only. Read the full abstract at the source